Jeffrey Boschwitz, Theresa Zhang, Felix Dawson
Personal Genome Diagnostics named Jeffrey Boschwitz its chief operating officer, Theresa Zhang its VP of research services, and Felix Dawson to its board. Boschwitz was formerly executive VP of operations and corporate development at Plus Diagnostics. Prior to that, he was VP of North American sales and marketing at Orchid Cellmark and has held positions at Quest Diagnostics and Booz Allen Hamilton.
Zhang joins PGDx from Merck Research Laboratories where she held various positions responsible for identification of predictive biomarkers and clinical implementation for oncology compounds. Dawson is a founding member of investment firm Wilkes Lane Capital. He previously was at Constellation Energy, now called Exelon, and at Goldman Sachs.